OncoPro Liquid Biopsy Test: Advanced Cancer Genetic Analysis
Revolutionary Non-Invasive Cancer Detection
The OncoPro Liquid Biopsy Test represents a groundbreaking advancement in cancer diagnostics, offering a comprehensive genetic analysis through a simple blood draw. This innovative test detects circulating tumor DNA (ctDNA) in the bloodstream, providing valuable insights into cancer genetics without the need for invasive tissue biopsies. As cancer cells die and release DNA fragments into the bloodstream, this test captures and analyzes these genetic markers to deliver precise information about tumor characteristics and genetic mutations.
What the OncoPro Liquid Biopsy Test Measures
This comprehensive test analyzes 73 critical cancer-related genes using advanced Next Generation Sequencing technology. The test detects:
- Genetic mutations across key cancer pathways
- Copy number variations and gene amplifications
- Microsatellite instability (MSI) status
- Tumor mutational burden indicators
- Actionable biomarkers for targeted therapy selection
Comprehensive Gene Panel Coverage
The test covers essential genes including BRCA1, BRCA2, EGFR, KRAS, TP53, ALK, BRAF, PIK3CA, and many others critical for cancer diagnosis and treatment planning. This extensive coverage ensures comprehensive assessment of multiple cancer types and treatment pathways.
Who Should Consider This Test
The OncoPro Liquid Biopsy Test is recommended for individuals experiencing:
- Unexplained cancer symptoms or suspicious findings
- Family history of cancer or genetic predisposition
- Need for treatment monitoring and response assessment
- Recurrent or metastatic cancer requiring genetic profiling
- Difficulty obtaining traditional tissue biopsies
- Monitoring for minimal residual disease after treatment
Key Benefits of OncoPro Liquid Biopsy Testing
Non-Invasive Procedure
Unlike traditional tissue biopsies that require surgical procedures, the liquid biopsy uses a simple blood draw, minimizing patient discomfort and reducing procedural risks.
Comprehensive Genetic Profiling
The 73-gene panel provides extensive coverage of cancer-related mutations, offering a complete picture of tumor genetics in a single test.
Personalized Treatment Guidance
Results help oncologists select targeted therapies based on specific genetic mutations, improving treatment efficacy and reducing unnecessary side effects.
Real-Time Monitoring
Regular testing allows for continuous monitoring of treatment response and early detection of resistance mutations or disease progression.
Early Detection Capabilities
The test can detect cancer-associated genetic changes before traditional imaging methods, enabling earlier intervention and improved outcomes.
Understanding Your Test Results
Your OncoPro Liquid Biopsy Test results will provide detailed information about:
- Detected Mutations: Specific genetic alterations found in circulating tumor DNA
- Actionable Biomarkers: Genetic changes that may respond to targeted therapies
- MSI Status: Microsatellite instability results indicating potential immunotherapy response
- Variant Allele Frequency: Percentage of mutated DNA in the sample, indicating tumor burden
- Clinical Significance: Interpretation of findings in the context of current treatment guidelines
All results are reviewed by board-certified molecular pathologists and include comprehensive clinical interpretations to guide your healthcare team in making informed treatment decisions.
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | OncoPro Liquid Biopsy Test |
| Discount Price | $4,826 USD |
| Regular Price | $5,362 USD |
| Turnaround Time | 35 Working Days |
| Sample Type | 20 mL whole blood in 2 Streck tubes |
| Sample Requirements | Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE |
| Required Forms | Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) |
Nationwide Accessibility
We have branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our extensive network ensures convenient access to this advanced testing regardless of your location.
Take Control of Your Cancer Journey
The OncoPro Liquid Biopsy Test empowers patients and healthcare providers with critical genetic information to make informed decisions about cancer care. Whether you’re seeking initial diagnosis, treatment guidance, or ongoing monitoring, this comprehensive test provides the genetic insights needed for personalized cancer management.
Ready to take the next step in your cancer care? Book your OncoPro Liquid Biopsy Test today by calling our dedicated healthcare team at +1(267) 388-9828. Our specialists are available to answer your questions and schedule your test at a location convenient for you.
